ACT
- NASDAQ - Finance-Mrtg&Rel Svc
Enact Holdings Inc
|
$22.49 |
+0.27
1.22%
|
$22.96
|
$25.10
|
-10.40% |
163,905 130.08%
|
126,000
|
Most Recent Note for ACT - 5/11/2022 12:21:21 PM
Consolidating above its 50 DMA line ($22.21). Quarterly comparisons through Mar '22 show waning sales revenues.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AZN
- NYSE - DRUGS - Drug Manufacturers - Major
Astrazeneca Plc Ads
|
$62.51 |
-1.13 -1.78%
|
$62.80
|
$71.70
|
-12.82% |
6,105,954 82.69%
|
7,384,000
|
Most Recent Note for AZN - 5/11/2022 12:23:21 PM
Slumping below its 50 DMA line after volume-driven losses. Showed very strong sales revenues and earnings increases in the Dec '21 and Mar '22 quarters versus the year ago periods. Prior quarterly and annual earnings history is not a match with the fundamental guidelines of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BCML
- NASDAQ - Banks-West/Southwest
Baycom Corp
|
$21.41 |
+0.52
2.47%
|
$21.50
|
$23.52
|
-8.99% |
59,197 82.22%
|
72,000
|
Most Recent Note for BCML - 5/11/2022 12:26:01 PM
Pulled back from its 52-week high and slumped below its 50 DMA line with recent volume-driven losses. Earnings increases in the 4 most recent quarterly comparisons through Mar '22 were above the +25% minimum guideline (C criteria). Prior quarters showed sub par sales revenues growth not indicative of a new product or service (N criteria) in great demand. Annual earnings (A criteria) has been up and down.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CTS
- NYSE - Elec-Semiconductor Mfg
C T S Corp
|
$36.15 |
+0.20
0.56%
|
$36.44
|
$39.49
|
-8.46% |
62,550 59.01%
|
106,000
|
Most Recent Note for CTS - 5/11/2022 12:26:47 PM
Recently rallied with volume-driven gains but met stubborn resistance again in the $38-39 area. Reported earnings +46% on +15% sales revenues for the Mar '22 quarter versus the year ago period. Three of the past 4 quarterly earnings increases were above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been up and down.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DGICA
- NASDAQ - Insurance-Prop/Cas/Titl
Donegal Group Inc Cl A
|
$15.02 |
+0.33
2.25%
|
$15.05
|
$15.79
|
-4.88% |
36,091 60.15%
|
60,000
|
Most Recent Note for DGICA - 5/11/2022 12:27:43 PM
Reported earnings +48% on +5% sales revenues for the Mar '22 quarter versus the year ago period. Prior mid-day reports repeatedly cautioned members - "Prior quarterly sales revenues and earnings growth has not been strong and steady. Annual earnings (A criteria) history also has been up and down."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FMAO
- NASDAQ - Banks-Midwest
Farmers & Merchants Banc
|
$37.46 |
+1.79
5.02%
|
$37.46
|
$41.64
|
-10.04% |
24,245 73.47%
|
33,000
|
Most Recent Note for FMAO - 5/11/2022 12:29:04 PM
It is extended from any sound base but finding support near its 50 DMA line with today's gain. Three of the past 4 quarterly comparisons through Mar '22 showed earnings above the +25% minimum guideline (C criteria). Prior history is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GSK
- NYSE - Medical-Diversified
Glaxosmithkline Plc Adr
|
$43.43 |
+0.01
0.01%
|
$43.51
|
$46.97
|
-7.55% |
5,347,941 106.66%
|
5,014,000
|
Most Recent Note for GSK - 5/11/2022 12:30:13 PM
Recently slumped below its 50 DMA line ($43.83). UK-based pharmaceuticals firm's quarterly comparisons through Mar '22 have not shown strong and steady earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HR
- NYSE - REAL ESTATE - REIT - Healthcare Facilities
Healthcare Realty Trust
|
$28.77 |
-1.38 -4.56%
|
$30.04
|
$33.77
|
-14.82% |
3,024,866 69.86%
|
4,330,000
|
Most Recent Note for HR - 5/11/2022 12:30:52 PM
Quarterly and annual earnings history is below the guidelines for the C and A criteria of the investment system. This REIT owns and manages properties associated with healthcare services.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ICL
- NYSE - Chemicals-Agricultural
I C L Group Ltd
|
$11.64 |
+1.38
13.45%
|
$11.78
|
$12.96
|
-10.19% |
1,373,702 100.93%
|
1,361,000
|
Most Recent Note for ICL - 5/11/2022 12:32:19 PM
It has not formed a sound base but gapped up today rebounding above its 50 DMA line ($11.53). Recent quarterly comparisons through Mar '22 showed strong earnings increases above the +25% minimum guideline (C criteria) and sales revenues growth rate has shown impressive acceleration. Up and down annual earnings (A criteria) leaves fundamental concerns.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IIVI
- NASDAQ - Electronic-Parts
Ii-Vi Incorporated
|
$65.70 |
+2.65
4.20%
|
$66.85
|
$75.23
|
-12.67% |
1,024,857 77.35%
|
1,325,000
|
Most Recent Note for IIVI - 5/11/2022 12:34:56 PM
Sputtering as fundamentals deteriorated since last noted near its all-time high in the 2/12/21 mid-day report. Reported earnings +4% on +6% sales revenues for the Mar '22 quarter versus the year ago period, its 4th consecutive quarterly comparison below the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth history has been good. Completed a new Public Offering on 7/02/20. Has a new CEO as of 9/01/16.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MRK
- NYSE - Medical-Ethical Drugs
Merck & Co Inc
|
$90.49 |
+2.68
3.05%
|
$90.81
|
$91.40
|
-1.00% |
7,315,032 66.05%
|
11,075,000
|
Most Recent Note for MRK - 5/11/2022 12:40:57 PM
Challenging its all-time high with today's gain. Earnings improved +84% on +50% sales revenues in the Mar '22 quarter versus the year ago period, its 4th quarterly comparison above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in in FY '20 earnings (A criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NC
- NYSE - ENERGY - Coal
Nacco Industries Cl A
|
$49.01 |
+3.00
6.51%
|
$49.97
|
$51.20
|
-4.28% |
21,415 59.49%
|
36,000
|
Most Recent Note for NC - 5/11/2022 12:42:41 PM
Hovering near its 52-week high. Last noted with caution in the 4/22/22 mid-day report - "Quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SANM
- NASDAQ - Elec-Contract Mfg
Sanmina Corp
|
$40.09 |
+0.19
0.48%
|
$41.20
|
$44.26
|
-9.42% |
417,696 102.13%
|
409,000
|
Most Recent Note for SANM - 5/11/2022 12:45:34 PM
Stalled last week after touching a new 52-week high. Reported earnings +13% on +12% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Its up and down annual earnings (A criteria) also is a concern, fundamentally.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SCSC
- NASDAQ - WHOLESALE - Computers Wholesale
Scansource Inc
|
$37.00 |
+4.25
12.98%
|
$37.10
|
$40.83
|
-9.38% |
101,942 94.39%
|
108,000
|
Most Recent Note for SCSC - 5/11/2022 12:47:51 PM
Posting a big gain today rallying toward its 52-week high. Recent quarterly comparisons through Mar '22 showed strong earnings increases above the +25% minimum (C criteria). A big downturn in FY '20 earnings is a flaw with respect to the A criteria of the investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SU
- NYSE - ENERGY - Oil & Gas Refining & Marketing
Suncor Energy Inc
|
$36.28 |
+1.94
5.63%
|
$36.70
|
$37.93
|
-4.36% |
5,429,721 66.54%
|
8,160,000
|
Most Recent Note for SU - 5/11/2022 12:50:29 PM
Found support at its 50 DMA line ($33.16) while enduring recent distributional pressure. Reported earnings +292% on +56% sales revenues for the Mar '22 quarter versus the year ago period. Fundamental concerns remain. Prior mid-day reports cautioned members - "Quarterly and annual earnings (C and A criteria) have been up and down."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VWTR
- NASDAQ - Utility-Water Supply
Vidler Water Resources
|
$15.64 |
+0.00
0.00%
|
$15.65
|
$17.24
|
-9.28% |
146,008 62.93%
|
232,000
|
Most Recent Note for VWTR - 5/11/2022 12:51:03 PM
Holding its ground following 4/14/22 M&A news with D.R. Horton Inc (DHI). Prior mid-day reports repeatedly noted - "Reported strong Dec '21 quarterly results but its prior earnings history is not a match with the fact-based investment system's fundamental guidelines (C and A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|